BeiGene
BGNE
#963
Rank
$20.02 B
Marketcap
$176.50
Share price
1.02%
Change (1 day)
0.71%
Change (1 year)
BeiGene is a Chinese pharmaceutical company engaged in the R&D, and commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

Market capitalization of BeiGene (BGNE)

Market cap: $20.02 Billion USD

As of December 2024 BeiGene has a market cap of $20.02 Billion USD. This makes BeiGene the world's 963th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of BeiGene from 2016 to 2024

End of year Market Cap

Year Marketcap Change
2024$20.02 B1.06%
2023$19.81 B-15.53%
2022$23.46 B-14.65%
2021$27.48 B14.39%
2020$24.03 B133.57%
2019$10.28 B23.44%
2018$8.33 B87.28%
2017$4.45 B269.44%
2016$1.20 B

End of Day market cap according to different sources

On Dec 20th, 2024 the market cap of BeiGene was reported to be:

$20.02 Billion USD
by Yahoo Finance info icon info icon
$20.02 Billion USD
by CompaniesMarketCap info icon info icon
$18.81 Billion USD
by Nasdaq info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
$20.9 M-99.90%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.03 B-94.83%๐Ÿ‡บ๐Ÿ‡ธ USA